Wehr, M. C., Hinrichs, W., Brzózka, M. M., Unterbarnscheidt, T., Herholt, A., Wintgens, J. P., Papiol, S., Soto-Bernardini, M. C., Kravchenko, M., Zhang, M., Nave, K.-A., Wichert, S. P., Falkai, P., Zhang, W., Schwab, M. H., & Rossner, M. J. (2017). Spironolactone is an antagonist of NRG1-ERBB4 signaling and schizophrenia-relevant endophenotypes in mice. EMBO Molecular Medicine, 9(10), 1448-1462. doi:10.15252/emmm.201707691.